The monocyte-macrophage axis in the intestine
Citations
28,685 citations
1,673 citations
1,404 citations
812 citations
177 citations
Cites background from "The monocyte-macrophage axis in the..."
...These findings provide further support that GPBAR1 could be exploited for the development of gut-specific therapies for IBDs without dampening the systemic immune system....
[...]
...Because glucocorticoids are widely used in the treatment of IBDs, we next investigated how BAR501 compares with dexamethasone, a synthetic glucocorticoid, in the treatment of TNBS colitis....
[...]
...IBDs have traditionally been treated with nonspecific immunosuppressive drugs (e.g., corticosteroids or azathioprine), anti-inflammatory agents (e.g., 5-aminosalicylic acid), and, more recently, with anti–TNF-a agents (3)....
[...]
...The present observations pave the way for the development of GPBAR1-based anti-inflammatory agents for the treatment of IBDs....
[...]
...Because macrophages are one of the most abundant leukocytes in the intestinal mucosa and are implicated in the pathogenesis of IBDs (23, 24), we have investigated whether treatment with BAR501 attenuates the inflammation and immune dysfunction in BALB/c mice treated with TNBS and modulates macrophage recruitment/activity....
[...]
References
28,685 citations
"The monocyte-macrophage axis in the..." refers background in this paper
...CCL2 have markedly reduced intestinal m/ pools [7,52]....
[...]
...recruitment mechanism, as intestinal m/ are not entirely absent in steady state CCR2 / and CCL2 / mice [7,52]....
[...]
4,196 citations
3,307 citations
"The monocyte-macrophage axis in the..." refers background in this paper
...The larger subset is Ly6C (Gr-1) and expresses high levels of CCR2 and CD62L, but low levels of CX3CR1 [33]....
[...]
...They express the CSF1R (CD115) and two subsets can be identified on the basis of Ly6C (or Gr-1) expression [33]....
[...]
...that replenished steady state macrophage populations [33]....
[...]
2,463 citations
2,302 citations